Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Extensive Stage Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC
- Status
- COMPLETED
- Phase
- PHASE3
Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
- Status
- UNKNOWN
- Phase
- PHASE2
Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy
- Status
- TERMINATED
- Phase
- NA
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body
- Status
- WITHDRAWN
- Phase
- NA
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1